A rapid electron-capture gas chromatographic procedure for the analysis of p-hydroxymephenytoin

Journal of Pharmacological and Toxicological Methods

Volumn 44, Issue 3, 2000, Pages 461-465

  Salsali, M ^a   Coutts, R T ^a   Baker, G B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Electron capture gas chromatography; p Hydroxymephenytoin; Pentafluorobenzoyl chloride; S (+) mephenytoin

Indexed keywords

4 HYDROXYMEPHENYTOIN; CYTOCHROME P450; DEXTRORPHAN; DRUG METABOLITE; FLUORINE DERIVATIVE; PENTAFLUOROBENZOYL CHLORIDE; PHENYTOIN DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; DERIVATIZATION; DRUG STRUCTURE; ELECTRON CAPTURE DETECTION; ENZYME SUBSTRATE; GAS CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY; REPRODUCIBILITY; STANDARD; STRUCTURE ANALYSIS;

ANTICONVULSANTS; CHROMATOGRAPHY, GAS; DEXTRORPHAN; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MEPHENYTOIN; MICROSOMES, LIVER; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0034443167     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(01)00113-7     Document Type: Article

References (28)

1. Electron-capture gas chromatographic analysis of β-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization
2. GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin
3. Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G→A-splice site mutation
4. Screening for hydroxylation and acetylation polymorphisms in man via simultaneous analysis of urinary metabolites of mephenytoin, dextromethorphan and caffeine by capillary electrophoretic procedures
5. Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes
6. Analysis of a monofluorinated analogue of amphetamine in brain tissue using gas chromatography with electron-capture detection
7. Cytochrome P-450-dependent hydroxylation in migraine
8. Lack of pharmacokinetic interaction between dextromethorphan, coumarin and mephenytoin in man after simultaneous administration
9. Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans
10. Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians
11. Genetic polymorphism of mephenytoin p (4′)-hydroxylation: Difference between Orientals and Caucasians
12. Mephenytoin metabolism in vitro by human liver
13. Polymorphism of debrisoquine and mephenytoin hydroxylation among Estonians
14. Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high performance liquid chromatography
15. Stereoselective metabolism of mephenytoin in man
16. The mass spectra of succinimides, hydantoins, oxazolidineiones and other medicinal anti-epileptic agents
17. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry
18. Assay of mephenytoin metabolism in human liver microsomes by high performance liquid chromatography
19. Metabolism and disposition of N-(2-cyanoethyl) amphetamine (fenproporex) and amphetamine: Study in the rat brain
20. Para-hydroxytranylcypromine: Presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue
21. Simultaneous analysis of N-(2-cyanoethyl) amphetamine (fenproporex), amphetamine and para-hydroxyamphetamine in rat brain
22. Rapid analysis of 2-phenylethylamine in tissues and body fluids utilizing pentafluorobenzoylation followed by electron-capture gas chromatography
23. Analysis of the antidepressant phenelzine in brain tissue and urine using electron-capture gas chromatography
24. Simple and selective assay of 4-hydroxymephenytoin in human urine using solid-phase extraction and high-performance liquid chromatography with electrochemical detection and its preliminary application to phenotyping test
25. Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism
26. Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation
27. High performance liquid chromatographic determination of urinary 4′-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans